Universe Pharmaceuticals INC (UPC)
| Previous close | 2.2800 |
| Open | 2.1700 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.9360 - 2.1733 |
| 52-week range | 0.7500 - 5.8800 |
| Volume | |
| Avg. volume | 97,293 |
| Market cap | 7.924M |
| Beta (5Y monthly) | 1.77 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.7000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireUniverse Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results
Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2023.
Simply Wall St.Universe Pharmaceuticals INC's (NASDAQ:UPC) Share Price Boosted 54% But Its Business Prospects Need A Lift Too
Universe Pharmaceuticals INC ( NASDAQ:UPC ) shareholders would be excited to see that the share price has had a great...
GlobeNewswireUniverse Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq L
